Unit of Cardiology, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University Hospital of Padua, University of Padua, Padua, Italy.
Unit of Cardiovascular Pathology, Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University Hospital of Padua, University of Padua, Padua, Italy.
Minerva Cardiol Angiol. 2022 Apr;70(2):273-284. doi: 10.23736/S2724-5683.21.05732-X. Epub 2021 Oct 29.
Myocarditis is an inflammatory heart muscle disease characterized by heterogeneous clinical presentation and outcome. Clinical heterogeneity of myocarditis, ranging from acute onset chest pain with electrocardiographic changes resembling an acute coronary syndrome, to arrhythmic storm and chronic decompensated heart failure, makes diagnosis challenging. However, a correct diagnosis is fundamental to proper patients' management and should always be seeked. Although a definite diagnosis is only provided by endomyocardial biopsy, the European Society of Cardiology task force on myocardial and pericardial diseases provided specific criteria for the diagnosis of clinically suspected myocarditis, which has been facilitated by the advent of noninvasive imaging tests (i.e. cardiovascular magnetic resonance based myocardial tissue characterization). Due to the heterogeneous presentation and disease course of myocarditis, a tailored treatment would be the best strategy, but a standardized management is still not available. However, over the years, new, promising therapies, such as antiviral and immune-suppressive treatment, have come side by side to the standard pharmacological heart treatment, i.e. antiheart failure medications. In this paper we will review the basic principles of myocarditis management in clinical practice, including diagnostic work-up, conventional and disease-specific therapy and patients' follow-up.
心肌炎是一种以临床表现和预后不均一为特征的炎性心肌疾病。心肌炎的临床表现存在异质性,范围从类似于急性冠状动脉综合征的急性胸痛伴心电图改变,到心律失常风暴和慢性代偿性心力衰竭,这使得诊断具有挑战性。然而,正确的诊断对于患者的恰当管理至关重要,应始终寻求正确的诊断。尽管通过心内膜心肌活检才能明确诊断,但欧洲心脏病学会心肌和心包疾病工作组为临床疑似心肌炎的诊断提供了具体标准,这得益于非侵入性成像检查(即基于心血管磁共振的心肌组织特征)的出现。由于心肌炎的临床表现和疾病进程存在异质性,个体化治疗可能是最佳策略,但目前尚无标准化的管理方法。然而,多年来,新的、有前途的治疗方法,如抗病毒和免疫抑制治疗,与标准的心脏药理学治疗(即抗心力衰竭药物)一起出现。本文将回顾心肌炎在临床实践中的管理基本原则,包括诊断方法、常规和疾病特异性治疗以及患者随访。